MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-02-0004867
Sain Medicaments Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.64 Cr
▲ 4% YoY
Net profit · FY 2025
₹9.36 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹4.33 Cr
EBITDA margin 15.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹11.18 Cr
Satisfied ₹8.49 Lakh
Company age
43 yrs
Est. 1983
Employees · EPFO
23
Provident fund records
About Sain Medicaments Private Limited
Data last updated:
Sain Medicaments Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1983PTC004015. Its GSTIN is 36AACCS8292F1Z3 (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Girish Gupta (Managing Director) and Sumit Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10 H V S Building Complexhyderabad Ap, Telangana, India – 500095.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.64 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹9.36 Lakh (net margin 0.3%) and EBITDA of ₹4.33 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SAIN Medicaments. As per MCA filings, the company has open charges of ₹11.18 Cr and satisfied charges of ₹8.49 Lakh on record. Court records list 18 cases involving the company, including 8 filed by the company and 10 filed against it; 5 cases are pending.
Sain Medicaments Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0004867). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saingroup.com.
Company details
CIN U24230TG1983PTC004015
Registration Number 004015
Incorporation Date 30 June 1983
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0004867
CIN history
Sain Medicaments has one previous CIN (Corporate Identification Number): U24230AP1983PTC004015. The current CIN is U24230TG1983PTC004015, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1983PTC004015 | Current |
| U24230AP1983PTC004015 | Previous |
Recognitions & Rankings of Sain Medicaments
Contact details
Sain Medicaments Private Limited's registered office is in Hyderabad, Telangana. Its website is saingroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address10 H V S Building Complexhyderabad Ap, Telangana, India – 500095
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sain Medicaments Private Limited, buy the company report.
Comprehensive company report
Sain Medicaments Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sain Medicaments operates one associated brand: SAIN Medicaments. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical Company manufacturing various forms of medicines like tablets, capsules, syrups, dry syrup, and suspension | saingroup.com |
Business activity
The main business activity of Sain Medicaments is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sain Medicaments Private Limited, buy the company report.
Financials of Sain Medicaments Private Limited
FY 2025 filings availableSain Medicaments Private Limited reported revenue of ₹27.64 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹27.64 Cr ▲ 4%
Net profit · FY 2025
₹9.36 Lakh margin 0.3%
EBITDA · FY 2025
₹4.33 Cr margin 15.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 5%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 11%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 4% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.7% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sain Medicaments Private Limited, buy the company report.
Board of directors of Sain Medicaments Private Limited
Sain Medicaments has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Agarwal Also directs: Sain Biocare Private Limited | Director | 01 Sep 2009 | 17 Years 2 Months | Current |
| Girish Gupta | Managing Director | 30 Jun 1983 | 43 Years 4 Months | Current |
| Manmeet Agarwal Also directs: Sain Biocare Private Limited | Director | 01 Jul 2011 | 15 Years 4 Months | Current |
Peer comparison
Sain Medicaments Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shreepati Pharmaceuticals Pvt Ltd | ₹27.91 Cr (FY 2025) | 7.0% | Indore, M.P, Madhya Pradesh, India | |||
| Memphis Vision Care Private Limited | ₹27.83 Cr (FY 2024) | 106.0% | Chhatral, Gujarat, India | |||
| Anthea Pharma Private Limited | ₹27.78 Cr (FY 2025) | 516.0% | Hyderabad, Telangana, India | |||
| Sain Medicaments Private Limitedthis company | ₹27.64 Cr (FY 2025) | ₹9.36 Lakh | 0.3% | 4.0% | 23 | Hyderabad, Telangana, India |
| Jips Pharmaceuticals Private Limited | ₹27.63 Cr (FY 2023) | 19.0% | Chandigarh, India | |||
| Quixotic Pharma Private Limited | ₹27.58 Cr (FY 2025) | -8.0% | Punjab, India | |||
| Augxen Pharma Private Limited | ₹27.52 Cr (FY 2025) | 134.0% | Bharuch, Gujarat, India |
To see the full peer comparison of Sain Medicaments Private Limited, buy the company report.
Auditor
Sain Medicaments Private Limited is audited by KPMD & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KPMD & CO | FY 2024 | 017760S |
Shareholding
The shareholding of Sain Medicaments Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sain Medicaments Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11.18 Cr
Satisfied charges
₹8.49 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Sep 2025 | 101193960 | Hdfc Bank Limited | ₹28.35 Lakh | Open | |
| 08 Sep 2023 | 100786754 | Hdfc Bank Limited | ₹34 Lakh | Open | |
| 19 May 2018 | 100182644 | Hdfc Bank Limited | ₹10.56 Cr | Open | |
| 17 Jun 1996 | 90136593 | Syndicate Bank | ₹2.49 Lakh | Satisfied | |
| 09 Mar 1995 | 90132086 | Syndicate Bank | ₹6 Lakh | Satisfied |
To see the full charge records of Sain Medicaments Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Sain Medicaments Private Limited has 18 court cases on record: 8 filed by Sain Medicaments, 10 filed against it. 5 cases are pending and 13 are disposed.
Total cases
18
Filed by the company
8
Filed against the company
10
Pending
5
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 6 | 5 |
| High courts | 8 | 4 | 0 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Dr. Reddys Laboratories Limited | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Martin & Harris Pvt Ltd and Ors | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Martin & Harris Pvt Ltd and Ors | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by Bal Pharma Ltd | Disposed |
| District court, North Goa, Goa | Civil suit | Filed against the company by Ms. CFL Pharmaceuticals Ltd., | Disposed |
To see the full case history of Sain Medicaments Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sain Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sain Medicaments Private Limited has a workforce of 23 employees on its EPFO records as of Nov 30, 2024, across 1 active EPFO establishment.
Employee count
23
Active EPFO establishments
1
Employee growth
9.52%
GST
Sain Medicaments has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCS8292F1Z3 | Telangana | Active | 01 Jul 2017 |
| 09AACCS8292F1Z0 | Uttar Pradesh | Active | 20 Jul 2023 |
To see the full GST registrations and return filing status of Sain Medicaments Private Limited, buy the company report.
Recent activity
Sain Medicaments Private Limited has 6 board changes on record since 1983: 3 appointments and 3 cessations. The latest: Kumud Agarwal ceased to be Director on 17 Feb 2026.
Ceased
Kumud Agarwal ceased to be Director.
AGM
Sain Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 101193960 was registered on 01 Sep 2025.
Filing
Sain Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 10.56 Cr registered on 19 May 2018 with Charge ID 100182644 was modified on 28 Oct 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.34 Cr with Charge ID 100786754 was registered on 08 Sep 2023.
Ceased
Radheshyam Kanodia Hazarilal ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.56 Cr with Charge ID 100182644 was registered on 19 May 2018.
Appointed
Manmeet Agarwal was appointed as Director.
Charges
A charge registered on 17 Jun 1996 via Charge ID 90136593 with Syndicate Bank was fully satisfied on 11 Apr 2011.
Charges
A charge registered on 09 Mar 1995 via Charge ID 90132086 with Syndicate Bank was fully satisfied on 11 Apr 2011.
Ceased
Sunil Radheshyam Gupta ceased to be Director.
5 earlier events are in the company report.
Frequently asked questions
Sain Medicaments is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 1983 (43+ years old) and is registered under CIN U24230TG1983PTC004015.
Sain Medicaments has 3 current directors:
- Girish Gupta - Managing Director
- Sumit Agarwal - Director
- Manmeet Agarwal - Director
The latest financial statements of Sain Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sain Medicaments is 36AACCS8292F1Z3, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 09AACCS8292F1Z0 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Sain Medicaments is U24230TG1983PTC004015. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sain Medicaments has 18 court cases on record: 8 filed by the company and 10 filed against it. 5 are pending. Most are in the district courts.
Sain Medicaments was incorporated on 30 June 1983, making it 43+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sain Medicaments by revenue are Shreepati Pharmaceuticals Pvt Ltd, Memphis Vision Care Private Limited, Anthea Pharma Private Limited, Jips Pharmaceuticals Private Limited, Quixotic Pharma Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kumud Agarwal ceased to be Director on 17 Feb 2026. Radheshyam Kanodia Hazarilal ceased to be Director on 22 Dec 2020. Manmeet Agarwal was appointed as Director on 01 Jul 2011. Sain Medicaments has 6 board changes on record in total.
Yes, Sain Medicaments is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0004867).
Sain Medicaments can be reached through the website saingroup.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages